Research facility · founded 1892

The Wistar Institute

Philadelphia, United States · wistar.org

Manage this page

Citations, last 5 years: 13.8k
Works, last 5 years: 2 014
h-index: 580
Scientists listed: 246
Grants since 2016: 630

Grants received

2008–2024 · program · P01

Targeted Therapies in Melanoma

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

$2.5MFerroptosis and cancer prognosis

2008–2024 · program · P01

Targeted Therapies in Melanoma

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

$2.5MFerroptosis and cancer prognosis

2008–2024 · program · P01

Administrative Core

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Biostatistics Core

Qin Liu · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Administrative Core

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

2008–2024 · program · P01

Biostatistics Core

Qin Liu · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Targeting HSP70 for MelanomaTherapy

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

2008–2024 · program · P01

Targeting PPT1 in the Tumor Microenvironment

Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Targeting Lipid Metabolism in the Tumor Microenvironment

Ashani T Weeraratna · The Wistar Institute · funded by National Institutes of Health

2008–2024 · program · P01

Targeting Lipid Metabolism in the Tumor Microenvironment

Ashani T Weeraratna · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Overcoming primary and secondary resistance in wild-type BRAF melanoma

Andrew Eric Aplin · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Targeting PPT1 in the Tumor Microenvironment

Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health

2008–2024 · program · P01

Targeting HSP70 for MelanomaTherapy

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Pathology Core

Xiaowei Xu · The Wistar Institute · funded by National Institutes of Health

2008–2025 · program · P01

Biology Core

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

2008–2024 · program · P01

Biology Core

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

2006–2028 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$410.2kViral-associated cancers and disorders

2006–2022 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$350.2kViral-associated cancers and disorders

2006–2022 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$361kViral-associated cancers and disorders

2006–2022 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$361kViral-associated cancers and disorders

2006–2028 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$410.2kViral-associated cancers and disorders

2006–2022 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$361kViral-associated cancers and disorders

2006–2023 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$353.8kViral-associated cancers and disorders

2006–2028 · research · R01

Epigenomic Control of KSHV Latency

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$410.2k

2005–2025 · research · R01

Functional Analysis of p53 Polymorphic Variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$391.2kCancer-related Molecular Pathways

2005–2021 · research · R01

Epigenetic Regulation of Epstein-Barr Virus

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$491.5kViral-associated cancers and disorders

2005–2021 · research · R01

Epigenetic Regulation of Epstein-Barr Virus

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$469kViral-associated cancers and disorders

2005–2021 · research · R01

Epigenetic Regulation of Epstein-Barr Virus

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$469kViral-associated cancers and disorders

2005–2025 · research · R01

Functional Analysis of p53 Polymorphic Variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$391.2k

2005–2025 · research · R01

Functional Analysis of p53 Polymorphic Variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$371.7kCancer-related Molecular Pathways

2005–2021 · research · R01

Epigenetic Regulation of Epstein-Barr Virus

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$469kViral-associated cancers and disorders

2005–2020 · research · R01

Functional Analysis of p53 polymorphic variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$384.8kCancer-related Molecular Pathways

2005–2020 · research · R01

Functional Analysis of p53 polymorphic variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$384.8kCancer-related Molecular Pathways

2005–2025 · research · R01

Functional Analysis of p53 Polymorphic Variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$90.4kCancer-related Molecular Pathways

2005–2020 · research · R01

Functional Analysis of p53 polymorphic variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$384.8kCancer-related Molecular Pathways

2005–2022 · research · R01

Epigenetic Regulation of Epstein-Barr Virus

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$469kViral-associated cancers and disorders

2005–2025 · research · R01

Functional Analysis of p53 Polymorphic Variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$383.4kCancer-related Molecular Pathways

2005–2026 · research · R01

Functional Analysis of p53 Polymorphic Variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$96k

2005–2026 · research · R01

Functional Analysis of p53 Polymorphic Variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$391.2k

2004–2020 · research · R01

Mechanism of myeloid cell defect in cancer

Dmitry I Gabrilovich · The Wistar Institute · funded by National Institutes of Health

$325.3k